Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-methoxy-5'-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro(cyclohexane-1,2'-inden-1',2'-imidazol)-4'-amine
2. Azd3293
1. 1383982-64-6
2. Azd-3293
3. Ly3314814
4. Azd3293
5. Lanabecestat [usan]
6. X8spj492vf
7. Lanabecestat (azd3293; Ly3314814)
8. Chembl4217620
9. Ly-3314814
10. Lanabecestat (usan)
11. (1,4-trans,1'r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro(cyclohexane-1,2'-indene-1',2''-imidazol)-4''-amine
12. (1r,1'r,4r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-- Dispiro(cyclohexane-1,2'-indene-1',2''-imidazol)-4''-amine
13. (1r,1'r,4r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine
14. Dispiro[cyclohexane-1,2'-[2h]indene-1'(3'h),2''-[2h]imidazol]-4''-amine, 4-methoxy-5''-methyl-6'-[5-(1-propyn-1-yl)-3-pyridinyl]-, (1alpha,1'r,4beta)-
15. Dispiro(cyclohexane-1,2'-(2h)indene-1'(3'h),2''-(2h)imidazol)-4''-amine, 4-methoxy-5''-methyl-6'-(5-(1-propyn-1-yl)-3-pyridinyl)-, (1alpha,1'r,4beta)-
16. Lanabecestat [inn]
17. Unii-x8spj492vf
18. Lanabecestat [who-dd]
19. Gtpl7789
20. Schembl9947926
21. Schembl9947930
22. Chembl3261045
23. Chembl3349234
24. Chembl3989948
25. Schembl10249890
26. Schembl20702043
27. Schembl23085139
28. Bdbm41537
29. Bdbm41542
30. Bdbm136733
31. Hms3886b08
32. Azd 3293
33. Bcp16986
34. Ex-a1471
35. Bdbm50012629
36. Bdbm50452874
37. S8193
38. Zinc95576075
39. Us8865911, 20a Isomer 1
40. Ccg-268796
41. Cs-7494
42. Db14814
43. Sb18857
44. Ac-33090
45. Lanabecestat(azd3293,ly-3314814)
46. Hy-100740
47. Ly 3314814
48. D10946
49. Us8865911, 114
50. Us8865911, 122
51. Q27293694
52. Azd-3293;azd 3293;ly-3314814;ly 3314814;ly3314814
53. (1r,1'r,4r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro(cyclohexane-1,2'-inden-1',2''-imidazol)-4''-amine
54. (1r,4r)-4-methoxy-5''-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine
55. 1383984-21-1
56. 4-methoxy-5'-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'h-dispiro(cyclohexane-1,2'-inden-1',2'-imidazol)-4'-amine
57. Dispiro(cyclohexane-1,2'-(2h)indene-1'(3'h),2''-(2h)imidazol)-4''-amine, 4-methoxy-5''-methyl-6'-(5-(1-propyn-1-yl)-3-pyridinyl)-, (1.alpha.,1'r,4.beta.)-
| Molecular Weight | 412.5 g/mol |
|---|---|
| Molecular Formula | C26H28N4O |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 412.22631153 g/mol |
| Monoisotopic Mass | 412.22631153 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 827 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
47
PharmaCompass offers a list of Lanabecestat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lanabecestat manufacturer or Lanabecestat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lanabecestat manufacturer or Lanabecestat supplier.
PharmaCompass also assists you with knowing the Lanabecestat API Price utilized in the formulation of products. Lanabecestat API Price is not always fixed or binding as the Lanabecestat Price is obtained through a variety of data sources. The Lanabecestat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lanabecestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanabecestat, including repackagers and relabelers. The FDA regulates Lanabecestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanabecestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lanabecestat supplier is an individual or a company that provides Lanabecestat active pharmaceutical ingredient (API) or Lanabecestat finished formulations upon request. The Lanabecestat suppliers may include Lanabecestat API manufacturers, exporters, distributors and traders.
Lanabecestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lanabecestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lanabecestat GMP manufacturer or Lanabecestat GMP API supplier for your needs.
A Lanabecestat CoA (Certificate of Analysis) is a formal document that attests to Lanabecestat's compliance with Lanabecestat specifications and serves as a tool for batch-level quality control.
Lanabecestat CoA mostly includes findings from lab analyses of a specific batch. For each Lanabecestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lanabecestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Lanabecestat EP), Lanabecestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lanabecestat USP).
